Detalhe da pesquisa
1.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Cell
; 175(4): 984-997.e24, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30388455
2.
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
Nature
; 620(7974): 651-659, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37468627
3.
Stromal changes in the aged lung induce an emergence from melanoma dormancy.
Nature
; 606(7913): 396-405, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35650435
4.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 633-644.e5, 2020 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31836388
5.
IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance.
Nature
; 589(7843): 597-602, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33361818
6.
ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ.
Nat Methods
; 19(11): 1403-1410, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36280724
7.
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Cell
; 141(4): 583-94, 2010 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-20478252
8.
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 565(7738): E4, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30532003
9.
MCU controls melanoma progression through a redox-controlled phenotype switch.
EMBO Rep
; 23(11): e54746, 2022 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36156348
10.
Corrigendum: Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Nature
; 555(7695): 274, 2018 03 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29466340
11.
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Nature
; 560(7718): 382-386, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30089911
12.
H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.
Drug Resist Updat
; 71: 100993, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37639774
13.
Autophagy Paradox: Strategizing Treatment Modality in Melanoma.
Curr Treat Options Oncol
; 24(2): 130-145, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36670319
14.
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Nature
; 546(7658): 431-435, 2017 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28607484
15.
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 550(7674): 133-136, 2017 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28953887
16.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 681, 2020 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32032511
17.
Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Proc Natl Acad Sci U S A
; 117(14): 8001-8012, 2020 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32193336
18.
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival.
EMBO J
; 37(20)2018 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30209241
19.
Retraction Note: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance.
Nature
; 599(7885): 518, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34580487
20.
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Pharmacol Res
; 173: 105911, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34560251